Heartseed
Tokyo
About Heartseed
Heartseed is a biotechnology research firm that specializes in the development of purified ventricular cardiomyocytes derived from induced pluripotent stem cells for the treatment of heart failure. The company employs an innovative methodology that involves the creation of cardiomyocyte spheroids, small clusters of heart cells, using stem cells. These spheroids are then surgically implanted into the heart to improve its performance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $86.3M
- Funding stage: IPO
- Last round: Series D (May 2023)
- Ticker: tyo:219A
- Website: heartseed.jp#
- Phone: +81 036-380-1068
Industries & Categories
Beauty, Biotechnology, Health Care, Medical, Nursing and Residential Care
Social Profiles
Canonical: https://fsome.com/organization/heartseed-82957 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.